Sched.com Conference Mobile Apps
PSHP 2026 Residency Conference has ended
PSHP 2026 Residency Conference
Sign up
or
log in
to add sessions to your schedule and sync them to your phone or calendar.
Residents & Preceptors
Schedule
Speakers
Platform Schedule (PDF)
CE Info
Exhibitors
Steer Committee
Venue Map
Sponsors
Search
Menu
Residents & Preceptors
Schedule
Speakers
Platform Schedule (PDF)
CE Info
Exhibitors
Steer Committee
Venue Map
Sponsors
Search
Share your event
Share via
or Copy link
Copy
Event Schedule
My Schedule
0
View
Simple
Expanded
Grid
By Venue
View
Simple
Expanded
Grid
By Venue
Monday
, May 18
a.Pavilion Hub EAST
9:30am •
Evaluating the Appropriateness of Venous Thromboembolism Prophylaxis in Hospitalized Patients
9:50am •
Evaluation of Anti-Xa Levels in Patients with Obesity Receiving Therapeutic Enoxaparin
10:10am •
Improving Pharmacy Quality Through Structured Governance: Quality Needs Assessment at the Hospital of the University of Pennsylvania
10:40am •
Dexmedetomidine Use on Recovery Time in General Laparoscopic/Robotic Procedures
11:00am •
Assessing Pennsylvania Community Pharmacists’ Understanding of Standard-of-Care (SOC) Regulatory Models
11:20am •
Outpatient Parenteral Antimicrobial Therapy in Patients with Limited Insurance Coverage: Cost Impact of Early Discharge with Long-Acting Dalbavancin
11:40am •
Lunch Networking Internal Medicine/Pharmacotherapy/Oncology
12:50pm •
Nutritional Support Guidance for Critically Ill Patients Receiving Multiple High Dose Pressors
1:10pm •
Evaluation of a Critical Care Phenobarbital Protocol for Alcohol Withdrawal Management
1:30pm •
Ketamine for Sedation in Mechanically Ventilated Critically Ill Patients: A Retrospective Study
2:00pm •
Empiric Yet Suboptimal: Assessment of Inappropriate Empiric Antibiotics for Pneumonia and Urinary Tract Infections in the Emergency Department
2:20pm •
Review of Institutional Emergency Medicine Pharmacotherapy to Acute Agitation and Violent Patients
2:40pm •
Evaluation Of Ketamine-Propofol Versus Propofol Alone For Procedural Sedation In Orthopedic Reductions
3:00pm •
Clinical Pearl: Making Enterprise-wide Medication-use Information More Widely Available
3:20pm •
Clinical Pearl: Current Concepts in Heart Failure
3:40pm •
Clinical Pearl: From Genotype to Guideline: Oncology Pharmacogenomics
a.Pavilion Hub WEST
9:30am •
Low- versus High- Dose Intravenous Methylprednisolone for High Eosinophilic Asthma and COPD Exacerbations in the Emergency Department
9:50am •
Intracranial Hemorrhage After Tenecteplase Administration for Acute Ischemic Stroke
10:10am •
Time to First Non-Benzodiazepine Antiseizure Medication in Status Epilepticus
10:40am •
Oral Stepdown Therapy for Gram-Negative Bacteremia in Obesity: High-Bioavailability Agents (Fluoroquinolones, Sulfamethoxazole-Trimethoprim) Versus Low-Bioavailability Agents (Beta-Lactams)
11:00am •
Oral Third Generation Cephalosporins versus Standard of Care for the Treatment of Penicillin-non-susceptible, Ceftriaxone-susceptible Alpha-hemolytic Streptococcal Infections
11:20am •
Comparison of Polymerase Chain Reaction (PCR) vs. Culture-Based Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screenings on Time to Vancomycin De-escalation during Pneumonia Treatment
11:40am •
Lunch Networking Infectious Diseases/Solid Organ Transplant
12:50pm •
Characterization of Delayed Infusion-Related Reactions with Polatuzumab vedotin (PV)
1:10pm •
Impact of a Clinic Based Solid Tumor Pharmacist, A Pilot Project
1:30pm •
Assessment Of The Efficacy Of IV Iron 1500 mg vs. 1000 mg On Hematologic Response
2:00pm •
Impact of bromocriptine on suspected neurogenic fever
2:20pm •
Lorazepam Usage with a Gabapentin Taper vs. No Taper for Inpatient Management of Alcohol Withdrawal
2:40pm •
Fixed Dose versus Titratable Vasopressin in Septic Shock: A Retrospective Chart Review
3:00pm •
Preceptor Pearl: Successful Failure in Precepting
3:20pm •
Preceptor Pearl: Small Patients, Big Learning. Precepting in Pediatric Pharmacy
3:40pm •
Preceptor Pearl: Supporting Professional Identity Formation in Pharmacy Trainees
Broad Hub EAST
9:30am •
Joint Effort: Implementation of a Clinical Pharmacist within a Rheumatology Clinic
9:50am •
Impact of Continuous Glucose Monitoring in Pharmacist-Led Medication Management in Type 2 Diabetes within a Collaborative Practice Agreement
10:10am •
Evaluating the Effect of GLP-1 Agonists on INR Time in Therapeutic Range for Warfarin Patients
10:40am •
Evaluating the Efficacy and Safety of Tapering Dexmedetomidine With and Without Clonidine in the Intensive Care Unit
11:00am •
Balancing Blood Pressure in Subarachnoid Hemorrhage: The Role of Vasopressors During Nimodipine Administration
11:20am •
Clinical Impact of Stress Dose Hydrocortisone Dosing Strategy During National Shortage
12:50pm •
Effect Of Glucagon-Like Peptide Receptor Agonists on Thyroid-Stimulating Hormone Levels and Levothyroxine Doses: A Retrospective Chart Review
1:10pm •
Reducing Inappropriate Use of Sulfonylureas in Older Veterans
1:30pm •
Bridging Education and Practice: Assessing Advanced Pharmacy Practice Experience Students’ Confidence in Medication Prescribing Upon Graduation
2:00pm •
Real-World Safety and Tolerability of Contemporary Dual Beta-Lactam Regimens Initiated During Hospitalization
2:20pm •
Real-World Implementation of Long-Acting Injectable Antiretroviral Therapy for HIV Treatment and Pre-Exposure Prophylaxis: Adherence, Retention, And Outcomes
2:40pm •
Evaluation of Antimicrobial Therapy and Clinical Outcomes for Patients with Streptococcus pneumoniae Bacteremia or Pneumonia with and without β-lactam Allergies
Broad Hub WEST
9:30am •
Adherence to Emergency Department Heart Failure Diuretic Panel Order Set
9:50am •
Pharmacist Intervention To Optimize Guideline-Directed Medication Therapy (GDMT) In Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)
10:10am •
Evaluation of Venous Thromboembolism Prophylaxis in Underweight and Overweight Patients Receiving Enoxaparin or Unfractionated Heparin
10:40am •
Dose by Design: Comparing the Clinical Utility of Low-Dose and Standard Buprenorphine Induction in a Community Hospital
11:00am •
Impact of Adjunctive Medications on Hospital Length of Stay in Medetomidine-Adulterated Opioid Withdrawal
11:20am •
A Quasi Experimental Evaluation of Dexmedetomidine Following Creation of a Clinical Guideline for α2 withdrawal.
11:40am •
Lunch Networking Ambulatory Care/Pediatrics
12:50pm •
Evaluating the Use and Safety of Amiodarone in Lung Transplant Recipients with New-Onset Post-Operative Atrial Arrhythmias: A Retrospective Cohort Study
1:10pm •
Comparing the Drug-Drug Interactions Between Tacrolimus and Low-dose Fluconazole Versus Clotrimazole for Oropharyngeal Candidiasis Prophylaxis in Kidney Transplant Recipients
1:30pm •
Evaluation of Insulin Use Post-Thoracic Transplant
2:00pm •
Evaluation of time to first dose antibiotics in neonates with late-onset sepsis in a level-III intensive care nursery
2:20pm •
Evaluation of RSV Prevention Equity
2:40pm •
Retrospective Review of a Neonatal Hypoglycemia Management Protocol Prior to Implementation of Oral Dextrose Gel
Forum (13th Floor Downstairs)
9:00am •
Kickoff & Preceptor of the Year Award Presentation
11:40am •
Lunch Networking Critical Care/Emergency Medicine/Cardiology
4:00pm •
Resident Phamily Feud
Franklin & Rittenhouse Square
11:40am •
Grab Provided Lunch (Take to Networking Session)
Franklin Square (13th Floor Downstairs)
8:00am •
Networking Breakfast
8:00am •
Registration
Midnight Boardroom
11:40am •
Lunch Networking Administration/Med Safety/Quality Improvement
Snow Boardroom
11:40am •
Lunch Networking Specialty/Community Pharmacy/Transitions of Care
Walnut Garden
5:00pm •
Optional Offsite Event Now at Walnut Garden *VENUE CHANGE* 1708 Walnut St.
Tuesday
, May 19
a.Pavilion Hub EAST
8:50am •
Announcements & Updates
9:00am •
Comparing Fentanyl Infusion Dosing Before and After Implementation of a Non-Weight-Based Approach in the Critical Care Unit
9:20am •
Trends in Sedative and Paralytic Exposures in Critically Ill Pediatric Patients During Three Different Time Periods
9:40am •
Comparison of Heparin versus Bivalirudin Therapy for Anticoagulation in Patients Receiving Extracorporeal Membrane Oxygenation
10:00am •
Evaluation of Initial Management for Acute Blood Pressure Control in Intracerebral Hemorrhage
10:30am •
Implementation of a Pharmacist-Driven Protocol for Ceftriaxone IV to PO Step-down in Hospitalized Patients with an Uncomplicated or Complicated Urinary Tract Infection
10:50am •
Incidence of Piperacillin/Tazobactam Reactions in Patients with Reported Beta-Lactam Reactions in a Community Hospital Setting
11:10am •
Evaluation of Carbapenem Therapy for Extended Spectrum β-Lactamase producing Enterobacterales (ESBL-E) Bloodstream Infections in Patients with and without Hypoalbuminemia
11:30am •
Impact of a Pharmacist-Driven Antimicrobial Stewardship Initiative on Time to Targeted Therapy for Enterobacterales Bacteremia
2:00pm •
Clinical Pearl: Emerging Therapies in Lipid Lowering
2:20pm •
Clinical Pearl: All in Favor Say AI: Key Considerations in AI for Critical Care Medicine
2:40pm •
Clinical Pearl: Pump It Up! Improving Patient Outcomes with Automated Insuin Delivery Systems for Type 2 Diabetes
a.Pavilion Hub WEST
8:50am •
Announcements & Updates
9:00am •
Evaluating Early Transition from Intravenous to Oral Antibiotics for Adult Patients with Community Acquired Pneumonia
9:20am •
Impact of Preoperative Antibiotic Timing on Odds of Surgical Site Infection
9:40am •
Effect of Inhaled Amikacin Liposome Dose Adjustments on Treatment Outcomes in Pulmonary Non-Tuberculous Mycobacteria Infections
10:00am •
Treatment Outcomes in Patients with Fungal Infections After Implementation of Weight Based Micafungin Dosing at a Large Academic Medical Center
10:30am •
Evaluation of Guideline-Recommended Weight-Based Initial Vancomycin Dosing in Septic Patients and the Effects on Therapeutic Level Achievement and Clinical Outcomes
10:50am •
Evaluation of the impact of anti-Xa monitoring for the prevention of venous thromboembolism (VTE) in trauma patients
11:10am •
Assessment of Bradycardia with Dexmedetomidine Use for Sedation in Non-Cardiac Intensive Care Units
2:00pm •
Preceptor Pearl: The Parfait Approach, Layered Learning Without the Crunch
2:20pm •
Preceptor Pearl: Mapping It Out - Preceptor Readiness Program
2:40pm •
Preceptor Pearl: Use of Custom Evaluations to Drive Consistent, Timely and Structured Resident Feedback
Broad Hub EAST
8:50am •
Announcements & Updates
9:00am •
Evaluation Of Universal Low-Intensity Pravastatin Therapy In De Novo Kidney Transplant Recipients
9:20am •
Assessing the Effect of Pharmacist Intervention on Inappropriate Beta-Blocker Prescribing for Essential Hypertension
9:40am •
Characterization of Semaglutide and Tirzepatide Prescribing and Tolerability After Therapy Lapse
10:00am •
Comparison of Appropriate Lipid Panel Monitoring in Patients Managed by Pharmacists and Non-Pharmacists at Temple University Health System (TUHS)
10:30am •
Evaluation of Implementation of an Agitation Protocol in an Emergency Department
10:50am •
Assessing High-Risk Behaviors in Veterans at the CMCVAMC through a Behavioral Health Initiative for Distributing Fentanyl Test Strips
11:10am •
Impact of IV Push Antibiotics Administered in the Emergency Department in Patients with Sepsis and Septic Shock
Broad Hub WEST
8:50am •
Announcements & Updates
9:00am •
Risk Factors for PTT Prolongation in Patients Receiving Continuous Heparin
9:20am •
Comparing The Safety and Effectiveness of Venous Thromboembolism Prophylaxis with Unfractionated Heparin Versus Enoxaparin in Patients with Cirrhosis and Chronic Liver Disease
9:40am •
Assessing Inpatient Pharmacist Role In Optimizing Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use In Patients With Heart Failure Prior To Discharge
10:30am •
Safety and Efficacy of Alpha-2 Agonists in the Setting of Fentanyl and Medetomidine Withdrawal
10:50am •
Assessment of Pharmacy Resident Education on Opioid with Suspected Adulterants Withdrawal Clinical Practice
11:10am •
Impact of a Two-Part Training Program to Support Naloxone Education and Community Outreach: Outcomes of the NAME Initiative
11:30am •
Evaluation of a Pharmacist Driven Naloxone Protocol on Inpatient Naloxone Prescribing: A Retrospective Chart Review
Forum (13th Floor Downstairs)
1:00pm •
Panel Discussion: From Residency Training to Practice Success
3:00pm •
Encore of Top 3 PGY1 Resident Platform Presentations
4:00pm •
PGY1 & PGY2 Award Announcements / Closing Comments
Franklin Square (13th Floor Downstairs)
8:00am •
Networking Breakfast
11:50am •
Lunch & Networking with Exhibitors
Filter By Date
May 18
-
19, 2026
Monday
, May 18
Tuesday
, May 19
Filter By Venue
Center City, Philadelphia
All
a.Pavilion Hub EAST
a.Pavilion Hub WEST
Broad Hub EAST
Broad Hub WEST
Forum (13th Floor Downstairs)
Franklin & Rittenhouse Square
Franklin Square (13th Floor Downstairs)
Midnight Boardroom
Snow Boardroom
Walnut Garden
Filter By Type
Acute Care Addiction Medicine/Pain Management
Addiction Medicine/Pain Management
Ambulatory Care
Cardiology
Critical Care
Emergency Medicine
Event
General Session
Infectious Diseases
Medication Safety/Quality Improvement
Oncology
Pediatrics
Pharmacotherapy
Pharmacy Operations
Registration
Resident Platforms
Session
Solid Organ Transplant
Popular
Share Modal
Share this link via
Or copy link
Copy
Filter sessions
Apply filters to sessions.
close
Dates
Monday
, May 18
Tuesday
, May 19
Session Type
Acute Care Addiction Medicine/Pain Management
Addiction Medicine/Pain Management
Ambulatory Care
Cardiology
Critical Care
Emergency Medicine
Event
General Session
Infectious Diseases
Medication Safety/Quality Improvement
Oncology
Pediatrics
Pharmacotherapy
Pharmacy Operations
Registration
Resident Platforms
Session
Solid Organ Transplant
Other Filters
Popular
